 Claudia Crocini
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 18 | 2026 | 550 | 3.080 |
Why?
| | Optogenetics | 4 | 2024 | 109 | 1.230 |
Why?
| | Cardiomyopathy, Hypertrophic | 5 | 2022 | 145 | 1.140 |
Why?
| | Heart | 5 | 2026 | 635 | 1.080 |
Why?
| | Cardiomegaly | 2 | 2025 | 172 | 0.980 |
Why?
| | Action Potentials | 9 | 2024 | 509 | 0.950 |
Why?
| | Myocardial Contraction | 6 | 2017 | 300 | 0.940 |
Why?
| | Boidae | 1 | 2024 | 25 | 0.830 |
Why?
| | Calcium Signaling | 6 | 2017 | 251 | 0.780 |
Why?
| | Arrhythmias, Cardiac | 4 | 2026 | 352 | 0.730 |
Why?
| | Myofibrils | 2 | 2024 | 49 | 0.670 |
Why?
| | Heart Failure | 4 | 2023 | 2181 | 0.670 |
Why?
| | Sarcolemma | 5 | 2024 | 39 | 0.610 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 687 | 0.600 |
Why?
| | Calcium | 4 | 2024 | 1184 | 0.580 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 85 | 0.560 |
Why?
| | Excitation Contraction Coupling | 4 | 2017 | 17 | 0.560 |
Why?
| | Channelrhodopsins | 1 | 2016 | 20 | 0.500 |
Why?
| | Adrenergic beta-Agonists | 1 | 2016 | 95 | 0.480 |
Why?
| | Electric Countershock | 1 | 2016 | 116 | 0.470 |
Why?
| | Biocompatible Materials | 1 | 2019 | 436 | 0.440 |
Why?
| | Muscle Cells | 1 | 2014 | 42 | 0.430 |
Why?
| | Muscle Proteins | 2 | 2013 | 248 | 0.420 |
Why?
| | Light | 1 | 2017 | 412 | 0.410 |
Why?
| | Heart Diseases | 2 | 2017 | 343 | 0.410 |
Why?
| | Animals | 25 | 2026 | 38331 | 0.370 |
Why?
| | Hydrogels | 1 | 2019 | 705 | 0.360 |
Why?
| | Myocardium | 6 | 2024 | 949 | 0.350 |
Why?
| | Heart Ventricles | 4 | 2018 | 754 | 0.350 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2022 | 358 | 0.340 |
Why?
| | Repressor Proteins | 1 | 2013 | 435 | 0.300 |
Why?
| | Tissue Engineering | 1 | 2013 | 446 | 0.280 |
Why?
| | Cardiomyopathies | 2 | 2023 | 335 | 0.280 |
Why?
| | Mutation | 6 | 2022 | 4132 | 0.280 |
Why?
| | Heart Atria | 2 | 2020 | 143 | 0.280 |
Why?
| | Intracellular Space | 2 | 2019 | 68 | 0.270 |
Why?
| | Nuclear Proteins | 1 | 2013 | 754 | 0.270 |
Why?
| | Cardiac Glycosides | 1 | 2026 | 2 | 0.240 |
Why?
| | Ouabain | 1 | 2026 | 19 | 0.240 |
Why?
| | Alternative Splicing | 2 | 2026 | 248 | 0.240 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2026 | 42 | 0.230 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 35 | 0.220 |
Why?
| | Organogenesis | 1 | 2026 | 65 | 0.220 |
Why?
| | Cells, Cultured | 5 | 2017 | 4177 | 0.220 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2026 | 137 | 0.220 |
Why?
| | Rats | 5 | 2020 | 5632 | 0.210 |
Why?
| | Rats, Wistar | 2 | 2016 | 460 | 0.210 |
Why?
| | Mice | 11 | 2026 | 18549 | 0.200 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2022 | 120 | 0.200 |
Why?
| | Postprandial Period | 1 | 2024 | 118 | 0.200 |
Why?
| | Gonadal Steroid Hormones | 1 | 2024 | 145 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2026 | 276 | 0.190 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4605 | 0.180 |
Why?
| | Green Fluorescent Proteins | 2 | 2014 | 406 | 0.180 |
Why?
| | Phenotype | 4 | 2019 | 3199 | 0.160 |
Why?
| | Rats, Inbred SHR | 1 | 2020 | 38 | 0.160 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 106 | 0.160 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 573 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2024 | 790 | 0.160 |
Why?
| | Dilatation | 1 | 2020 | 70 | 0.150 |
Why?
| | Capillaries | 1 | 2020 | 124 | 0.150 |
Why?
| | Capsules | 1 | 2019 | 43 | 0.150 |
Why?
| | Optical Imaging | 2 | 2018 | 64 | 0.150 |
Why?
| | Troponin T | 2 | 2017 | 68 | 0.150 |
Why?
| | Sarcoplasmic Reticulum | 2 | 2017 | 43 | 0.140 |
Why?
| | Coronary Vessels | 1 | 2020 | 250 | 0.140 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 94 | 0.140 |
Why?
| | Myosin Heavy Chains | 1 | 2019 | 186 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 946 | 0.140 |
Why?
| | Microscopy, Confocal | 2 | 2017 | 324 | 0.140 |
Why?
| | Atrioventricular Block | 1 | 2018 | 45 | 0.140 |
Why?
| | Electric Stimulation Therapy | 1 | 2018 | 81 | 0.130 |
Why?
| | Protein Transport | 1 | 2019 | 445 | 0.130 |
Why?
| | Cell Surface Extensions | 1 | 2017 | 14 | 0.130 |
Why?
| | Ranolazine | 1 | 2017 | 25 | 0.130 |
Why?
| | Sodium Channel Blockers | 1 | 2017 | 24 | 0.130 |
Why?
| | Extracellular Space | 1 | 2017 | 132 | 0.120 |
Why?
| | Heart Conduction System | 1 | 2017 | 93 | 0.120 |
Why?
| | Diet | 1 | 2024 | 1277 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 769 | 0.120 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2016 | 61 | 0.120 |
Why?
| | Sodium | 1 | 2017 | 198 | 0.120 |
Why?
| | Cell Survival | 1 | 2019 | 1113 | 0.120 |
Why?
| | Ion Transport | 1 | 2015 | 63 | 0.120 |
Why?
| | Fibroblasts | 1 | 2021 | 1042 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2013 | 163 | 0.110 |
Why?
| | Humans | 15 | 2026 | 144857 | 0.110 |
Why?
| | Actin Cytoskeleton | 1 | 2015 | 105 | 0.110 |
Why?
| | Equipment Design | 1 | 2016 | 534 | 0.110 |
Why?
| | Polyethylene Glycols | 1 | 2019 | 646 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 519 | 0.100 |
Why?
| | Proteasome Inhibitors | 1 | 2013 | 43 | 0.100 |
Why?
| | Haploinsufficiency | 1 | 2013 | 57 | 0.100 |
Why?
| | Lamin Type A | 1 | 2013 | 51 | 0.100 |
Why?
| | Transduction, Genetic | 1 | 2013 | 138 | 0.090 |
Why?
| | Dependovirus | 1 | 2013 | 79 | 0.090 |
Why?
| | LIM Domain Proteins | 1 | 2012 | 21 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2108 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 376 | 0.090 |
Why?
| | Heterozygote | 1 | 2013 | 316 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2019 | 2196 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2013 | 345 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2543 | 0.090 |
Why?
| | Oligopeptides | 1 | 2013 | 267 | 0.080 |
Why?
| | Male | 11 | 2025 | 72189 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 6067 | 0.080 |
Why?
| | Transfection | 1 | 2013 | 952 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1517 | 0.080 |
Why?
| | Animals, Newborn | 1 | 2013 | 904 | 0.080 |
Why?
| | Membrane Potentials | 2 | 2024 | 280 | 0.080 |
Why?
| | Models, Biological | 1 | 2017 | 1837 | 0.080 |
Why?
| | Rats, Inbred WKY | 2 | 2020 | 37 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 467 | 0.070 |
Why?
| | Mice, Knockout | 1 | 2015 | 3147 | 0.070 |
Why?
| | Genotype | 1 | 2013 | 1841 | 0.070 |
Why?
| | Heart Rate | 2 | 2026 | 847 | 0.070 |
Why?
| | Sex Factors | 2 | 2024 | 2090 | 0.060 |
Why?
| | Aging | 1 | 2017 | 1980 | 0.060 |
Why?
| | Time Factors | 2 | 2017 | 7107 | 0.060 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2026 | 56 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2026 | 2060 | 0.060 |
Why?
| | Chickens | 1 | 2026 | 192 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2633 | 0.050 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 248 | 0.050 |
Why?
| | Autophagy | 1 | 2025 | 288 | 0.050 |
Why?
| | Isoproterenol | 1 | 2022 | 97 | 0.040 |
Why?
| | Sarcomeres | 1 | 2022 | 99 | 0.040 |
Why?
| | Angiotensin II | 1 | 2022 | 97 | 0.040 |
Why?
| | Myosins | 1 | 2022 | 138 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2026 | 907 | 0.040 |
Why?
| | Cell Membrane | 1 | 2024 | 710 | 0.040 |
Why?
| | Female | 6 | 2026 | 78217 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2020 | 60 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2021 | 144 | 0.040 |
Why?
| | Transcriptome | 1 | 2026 | 1060 | 0.040 |
Why?
| | Vascular Remodeling | 1 | 2020 | 204 | 0.030 |
Why?
| | Swine | 1 | 2021 | 843 | 0.030 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 83 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2020 | 352 | 0.030 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2017 | 20 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2021 | 564 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 167 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 586 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2017 | 116 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1196 | 0.030 |
Why?
| | Hemodynamics | 1 | 2020 | 1117 | 0.030 |
Why?
| | Blotting, Western | 1 | 2017 | 1207 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 374 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 522 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2017 | 586 | 0.020 |
Why?
| | Ubiquitin | 1 | 2013 | 86 | 0.020 |
Why?
| | Proteolysis | 1 | 2013 | 177 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 197 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7197 | 0.020 |
Why?
| | Pedigree | 1 | 2012 | 514 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2013 | 619 | 0.020 |
Why?
| | Signal Transduction | 1 | 2022 | 5277 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2411 | 0.020 |
Why?
| | Disease Progression | 1 | 2013 | 2881 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3861 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2012 | 3628 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1810 | 0.010 |
Why?
| | Young Adult | 1 | 2012 | 14033 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 22396 | 0.010 |
Why?
| | Child | 1 | 2012 | 22620 | 0.010 |
Why?
| | Aged | 1 | 2012 | 25822 | 0.010 |
Why?
| | Middle Aged | 1 | 2012 | 35939 | 0.000 |
Why?
| | Adult | 1 | 2012 | 40438 | 0.000 |
Why?
|
|
Crocini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|